» Authors » Leonardo Pace

Leonardo Pace

Explore the profile of Leonardo Pace including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 75
Citations 721
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nappi C, Megna R, Zampella E, Volpe F, Piscopo L, Falzarano M, et al.
Eur J Nucl Med Mol Imaging . 2025 Feb; PMID: 39994020
Purpose: We performed an external validation of a predictive model for persistent/metastatic disease in patients with differentiated thyroid cancer (DTC) at post-treatment I whole-body scintigraphy (WBS). Methods: Our study population...
2.
Nappi C, Zampella E, Gaudieri V, Volpe F, Piscopo L, Vallone C, et al.
J Clin Med . 2024 Jan; 13(2). PMID: 38276075
Background: Patients with differentiated thyroid cancer (DTC) are referred to radioactive I (RAI) therapy and post-therapy I whole-body scintigraphy (WBS) to identify local and/or remote metastases. Positron emission tomography (PET)/computed...
3.
Piscopo L, Zampella E, Volpe F, Gaudieri V, Nappi C, Cutillo P, et al.
Cancers (Basel) . 2023 Aug; 15(16). PMID: 37627224
We assessed the outcome of administration of empiric radioactive iodine (RAI) therapy to patients with differentiated thyroid cancer (DTC), in a propensity-score-matched cohort of patients with biochemical incomplete response (BIR)...
4.
Zampella E, Piscopo L, Manganelli M, Volpe F, Nappi C, Gaudieri V, et al.
Endocrine . 2023 Jan; 80(3):612-618. PMID: 36692657
Purpose: In pediatric patients with differentiated thyroid cancer (DTC) we assessed the prognostic value of the 12-month response to therapy after initial treatment with surgery and radioactive iodine (RAI). Methods:...
5.
Piscopo L, Volpe F, Nappi C, Zampella E, Manganelli M, Matrisciano F, et al.
Curr Oncol . 2023 Jan; 30(1):37-44. PMID: 36661652
Second primary malignancies (SPM) are described as any primary, not synchronous, malignancy arising in a different anatomical district, with confirmed histological diagnosis. Age at diagnosis, previous non-thyroidal primary malignancy, and...
6.
Amboni M, Ricciardi C, Adamo S, Nicolai E, Volzone A, Erro R, et al.
Front Neurol . 2022 Dec; 13:1010147. PMID: 36468069
Background: Clinical markers of cognitive decline in Parkinson's disease (PD) encompass several mental non-motor symptoms such as hallucinations, apathy, anxiety, and depression. Furthermore, freezing of gait (FOG) and specific gait...
7.
Piscopo L, Nappi C, Volpe F, Romeo V, Nicolai E, Gallicchio R, et al.
Cancers (Basel) . 2022 Jun; 14(12). PMID: 35740623
Background: Hybrid positron emission tomography (PET)/magnetic resonance (MR) is an emerging imaging modality with great potential to provide complementary data acquired at the same time, under the same physiological conditions....
8.
Castaldo R, Garbino N, Cavaliere C, Incoronato M, Basso L, Cuocolo R, et al.
Diagnostics (Basel) . 2022 Feb; 12(2). PMID: 35204589
Radiomics is rapidly advancing in precision diagnostics and cancer treatment. However, there are several challenges that need to be addressed before translation to clinical use. This study presents an ad-hoc...
9.
Califano A, Caputo A, DAntonio A, Ciccone V, Fabiano M, Maiorino F, et al.
Urologia . 2021 Dec; 89(4):529-534. PMID: 34965795
Background: Prostate cancer is the second most commonly diagnosed cancer in men. The diagnostic accuracy in prostate cancer can be increased by employing a preliminary multiparametric MRI followed by a...
10.
Klain M, Zampella E, Piscopo L, Volpe F, Manganelli M, Masone S, et al.
Cancers (Basel) . 2021 Sep; 13(17). PMID: 34503148
This study assessed the long-term predictive value of the response to therapy, evaluated by serum thyroglobulin (Tg) determination and neck ultrasound, and estimated the potential additional impact of diagnostic whole-body...